Introduction {#s1}
============

The health benefits of exercise are indisputable. Exercise not only reduces cardiac risk factors and improves cardiac function, but also reduces mortality and morbidity from various cardiovascular diseases ([@B68]; [@B127]; [@B96]; [@B4]; [@B17]). Some researchers have demonstrated the cardiac protective effect of regular exercise on patients with cardiovascular disease ([@B31]), and endurance training can improve cardiac performance by transforming pathological cardiac hypertrophy into a physiological state ([@B37]). However, the exact mechanism of this cardiac adaptation is not fully understood.

Notably, exercise can induce physiological cardiac hypertrophy ([@B31]; [@B139]; [@B140]). In this state, myocardial hypertrophy has normal or enhanced contractile function, considered adaptive, and is not a risk factor for heart failure ([@B114]). Physiological cardiac hypertrophy is characterized by mild heart growth, its mass is usually 10%‑20% higher than that of normalized heart ([@B76]). The physiological hypertrophy of myocardium induced by exercise training is different from pathological hypertrophy at the stimulation mode, structure, and molecular level ([@B82]). In a study of myocardial gene expression profile in rats, it was shown that during exercise-induced physiological myocardial hypertrophy, the glucose signal of cardiomyocytes was significantly different, while there was no significant change in pathological hypertrophy ([@B66]). A large number of studies have proved that the metabolic coordination is an essential condition for myocardial adaptive growth ([@B128]; [@B98]; [@B35]; [@B40]; [@B49]), but it is not clear whether the regulation of myocardial energy metabolism can reverse myocardial remodeling and improve myocardial function. Therefore, the study of energy metabolism in exercise-induced physiological cardiac hypertrophy is beneficial to the exploration of exercise-induced cardiac adaptation and might be a unique research perspective for interventions in heart failure and other cardiovascular diseases. This review describes the variation of energy metabolism in exercise-induced physiological myocardial hypertrophy from three aspects: fatty acid metabolism, carbohydrate metabolism, and mitochondrial adaptation, and summarizes the related signal molecules ([**Figure 1**](#f1){ref-type="fig"}) and possible regulatory pathways of this energy metabolism ([**Figure 2**](#f2){ref-type="fig"}).

![A schematic of the major signaling molecules of metabolism in exercise-induced physiological myocardial hypertrophy, showing integration and cross-talk of various pathways.](fphar-11-01133-g001){#f1}

![A schematic overview of probable regulatory mechanism of energy metabolism during exercise-induced heart growth, such as autophagy, post-translational modification, microRNAs, angiogenesis, and inflammation.](fphar-11-01133-g002){#f2}

Changes of Myocardial Metabolism in Exercise-Induced Physiologic Cardiac Hypertrophy {#s2}
====================================================================================

The heart has to keep contracting to provide the body with the oxygen and nutrients it needs. Under normal physiological conditions, due to the small storage of high energy phosphate in cardiac myocytes, normal heart function depends on the tight coupling of intracellular ATP production and myocardial contraction ([@B65]), and ATP is mainly derived from the catabolism of glucose and fatty acids. Glucose oxidation is a key source of myocardial ATP. In healthy adults, the heart obtains about 50%‑70% of myocardial acetyl CoA derived ATP from fatty acids ([@B73]). When endogenous fatty acid supply is reduced, intracellular triacylglycerol hydrolyzes the fatty acid back through specific lipases including adipose triglyceride lipase (ATGL) ([@B44]; [@B61]) for fatty acid oxidation and subsequent ATP generation. The efficient absorption and recycling of fatty acids by the heart is the key to ensuring ATP supply and systolic function ([@B62]), and glycolysis produces less than 10% of total ATP in healthy hearts ([@B75]). The main pathway for ATP resynthesis is mitochondrial oxidative phosphorylation (\>98%), which is driven by the reduction equivalent NADH and FADH2 produced by fatty acid oxidation, pyruvate oxidation, and Krebs cycle. In a healthy heart, the hydrolysis rate of ATP matches the rate of ATP resynthesis, and the tissue content of ATP is very constant, even though the conversion rate of ATP is greatly raised ([@B120]). The elevated acute load during exercise has a strong effect on myocardial metabolism ([@B39]). In the heart, exercise boosts contractility and oxygen consumption, which is 10 times higher than the resting rate ([@B94]). Although the heart can take advantage of substrates including carbohydrates, lipids, amino acids, and ketone bodies, to provide energy, while its substrate preference vary under both physiological and pathological stress ([@B106]). The changes of substrate utilization and mitochondrial adaptation induced by exercise in physiological cardiomyocytes are effective guarantees to maintain the normal myocardial cells function.

Fatty Acid Metabolism {#s2_1}
---------------------

Exercise heightens fat catabolism in adipose tissue and increases triglycerides and free fatty acids in plasma, thus promoting the utilization of fatty acids. It was found that the myocardial hypertrophy of female mice after exercise was significantly enhanced compared with that of male mice, which may be related to the heightened level of free fatty acid in plasma caused by exercise ([@B32]). During exercise, hormone-mediated lipid interpretation of fatty acid metabolites in adipose tissue during exercise potentially promotes cardiac physiological growth by activating G-protein-coupled receptors (GPCRs), Akt, or nuclear receptors ([@B33]). Not only did free fatty acids increase rapidly with exercise ([@B34]), but they also seemed to remain elevated during exercise adaptation, and the elevated levels of free fatty acids in plasma were considered sufficient to promote cardiac fat catabolism ([@B97]; [@B87]). The uptake of free fatty acids by cardiomyocytes was achieved through plasma membrane transporters, fatty acid translocases (FAT/CD36), fatty acid transporters (FATP), and to a lesser extent, transmembrane diffusion. CD36 deficiency will result in defective fatty acid uptake ([@B126]; [@B3]). In exercise-induced physiological myocardial hypertrophy, fatty acid and glucose oxidation are enhanced, accompanied by increasing gene expression of encoding fatty acid transporters, fatty acid binding proteins, and lipid metabolic pathways ([@B122]; [@B27]; [@B90]). After fatty acid uptake and conjugation with acetyl CoA (FA-CoA), FA-CoA enters the mitochondria, *via* the carnitine acyl transferase shuttle (CPT-1 and CPT-2) ([@B1]). CPT-I and CPT-II are responsible for the input of mitochondrial fatty acids and control the rate-limiting steps of the mitochondrial fatty acid oxidation pathway ([@B69]). The up-regulated expressions of CPT-I and CPT-II were found in a mice model of exercise training and CPT-II mRNA expression was significantly heightened in exercise-induced physiologic myocardial hypertrophy ([@B52]). Acetyl coenzyme A carboxylase (ACC) is a key enzyme in fatty acid synthesis. An increase in ACC phosphorylation was observed in cardiomyocytes during moderate exercise training, including the phosphorylation of ACC-1 (265 kDa) and ACC-2 (280 kDa) ([@B26]). It is possible that ACC phosphorylation reduces the generation of malonyl coenzyme A, thereby indirectly lightening its inhibition of CPT-I activity, increasing the level of free fatty acids in plasma ([@B10]; [@B2]), and playing an important role in regulating fatty acid oxidation ([@B73]).

Carbohydrate Metabolism {#s2_2}
-----------------------

Glucose uptake in the heart was found to be transversely distributed, and the subendocardial layer is about 30% higher than the epicardial layer. The altered transmural distribution of glucose uptake after exercise probably reflects the metabolic adaptation of different myocardial layers to the physiologic growth of cardiomyocytes induced by exercise ([@B125]; [@B58]; [@B59]). It was found that exercise training elevated GLUT4 mRNA levels of left ventricle in rats ([@B131]). The myocardial glucose uptake was significantly higher in the exercise group than that in the rest group ([@B38]; [@B60]). In addition, experimental studies have demonstrated that the elevation of catecholamine and intracellular calcium concentration can raise GLUT4 translocation in the heart ([@B102]), while exercise can activate the sympathetic nerve, elevate catecholamine levels in the body, strengthen calcium concentration and myocardial contractility in cardiomyocytes. These mechanisms may all play a role in promoting glucose uptake during exercise. At the same time, studies have indicated that the glucose utilization rate of cardiomyocytes in the exercise group is significantly lower than that in the control group ([@B87]). At present, only pyruvate kinase activity has been found to be elevated in exercise-adapted rat hearts ([@B143]; [@B123]), but little is known about the effect of exercise on rate-limiting enzymes in glycolysis pathway. Glycolysis, aerobic oxidation of glucose and glycogen synthesis, were all enhanced *in vitro* perfusion hearts of exercise-adapted mice ([@B103]). However, in exercise-adapted rats, basal myocardial glycolysis was reduced despite increased myocardial glucose and palmitate oxidation ([@B24]). Differences between the two studies may be due to differences in animal models (such as rodent species, exercise type) or differences in cardiac perfusion regiments (matrix levels, hormone addition). It was found that the glycogen accumulation in the perfused heart of exercise training adapted mice ([@B103]) may be due to the increased glucose uptake stimulated by insulin ([@B55]). The cardiac glycogen is a potential source of myocardial energy ([@B5]), and glycogen resynthesis after exercise contributes to glucose homeostasis. Recent studies have manifested that cardiac-specific expression of a kinase-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase transgene lowered glycolytic rate and regulated the expression of genes known to promote cardiac growth ([@B21]; [@B18]; [@B41]). These researches further illustrated that depressed glycolytic activity appeared to be important in exercise-induced physiological cardiac hypertrophy. These experimental results showed that although glucose uptake, aerobic oxidation, and glycogen synthesis are all prolonged in exercise-induced hypertrophic myocardium, cardiomyocytes still give priority to fatty acid oxidation to provide energy. Metabolic adaptation maintains the balance between glucose and fatty acid catabolism on the premise of improving the efficiency of cardiac energy production.

Mitochondrial Adaptation {#s2_3}
------------------------

The role of mitochondria in physiological myocardial hypertrophy cannot be ignored. Exercise training promoted mitochondrial biosynthesis in the heart ([@B131]), which was related to exercise-induced cardiac hypertrophy ([@B136]; [@B104]; [@B1]). A recent study showed that a single exhausting exercise in untrained or trained rats resulted in increasing levels of cytochrome C, Caspase3, and mitochondrial DNA deletion ([@B50]), suggesting that mitochondrial damage may be an indirect signal to activate mitochondrial biogenesis. It was found that mitochondrial DNA synthesis, electron transport chain related enzyme activity and citrate synthase activity all increased in the hearts of swimming training mice ([@B103]). The energy consumption of the heart during exercise is several times higher than that of the resting state, which is related to the increasing of oxygen consumption and mitochondrial ATP production rate. Meanwhile, the myocardial mitochondrial ATP production rate must be highly matched with the ATP decomposition rate. Swimming training induced the enhancement of mitochondrial respiration and ATP production in physiological myocardial hypertrophy of mice ([@B9]), and some experiments proved that the mitochondrial respiration of isolated myocardium of mice also increased after exercise training, which was consistent with the change of gene expression of fatty acid utilization ([@B95]). In addition, exercise training promotes myocardial physiological hypertrophy while carrying out adaptive remodeling of mitochondria ([@B19]). Eight weeks of exercise conditioned training increased the number of myocardial mitochondria, especially the smaller ones ([@B30]). In mice, exercise strongly promotes the division of myocardial mitochondria, thereby enhancing the function of mitochondria; these mitochondrial changes occur in a manner dependent on adrenergic signals ([@B25]). In cardiomyocytes, mitochondria are considered to be the main source of reactive oxygen species. Under normal/basic conditions, ROS is produced as a by-product of mitochondrial electron transfer activity and is buffered by antioxidant systems. Exercise-induced reactive oxygen species may have beneficial effects on heart growth ([@B108]; [@B6]; [@B112]), probably because ROS, a second messenger to change redox sensitive enzymes, contributes to exercise-induced mitochondrial adaptive signal transduction.

The above studies showed that the adjustment of myocardial energy metabolism contributes to exercise-induced physiological myocardial hypertrophy. Although fatty acids seem to favor energy production, the heart has the ability to respond quickly to variation in matrix availability, ensuring that ATP production continues to meet its energy needs ([@B124]; [@B51]; [@B116]). Therefore, exercise training is related to the regulation of fatty acid, glucose metabolism and mitochondrial adaptation, which may further promote the coordination of myocardial metabolic flexibility and myocyte physiological hypertrophy. However, the specific mechanism is still not well understood and needs further study.

The Signaling Molecules of Metabolism in Exercise-Induced Physiological Myocardial Hypertrophy {#s3}
==============================================================================================

PGC-1α {#s3_1}
------

Peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) is a transcriptional coactivator initially identified as a cold-inducing factor involved in the mitochondrial biogenesis of brown adipocytes ([@B99]). PGC-1α is required for the normal reserve of fatty acid oxidation (FAO) ([@B70]; [@B98]), and PGC-1β for the normal expression of OXPHOS gene ([@B132]). PGC-1α/β promotes coordination of gene transcription, mitochondrial biosynthesis, and growth signal at various levels of oxidative metabolism ([@B107]). The expression of PGC-1α increases in exercise-induced myocardial hypertrophy, which promotes the production of mitochondria and the ability of fatty acid oxidation (FAO) ([@B95]; [@B135]; [@B103]). The cardiac function of adult PGC-1α/β-deficient mice does not show obvious abnormalities, but the expression of genes related to the mitochondrial energy transmission pathway (including FAO, tricarboxylic acid cycle, ETC/OXPHOS) in the gene expression profile is significantly and widely down-regulated ([@B79]). It is probably that PGC-1α/β is not necessary to maintain mitochondrial density and cardiac function in the basal state ([@B130]), but in the process of exercise-induced physiological myocardial growth, it is necessary to maintain the high volume respiratory function of hypertrophic myocardial mitochondria by driving the expression of genes related to mitochondrial energy conduction and ATP synthesis pathway. PGC-1α also promotes a broader mitochondrial biological response through interaction with estrogen-related receptors (ERR) and nuclear receptor factor 1 (NRF-1) ([@B111]). Studies have demonstrated that, ERR directly activates mitochondrial energy metabolism involving TCA cycle, electron transfer, and oxidative phosphorylation in cardiomyocytes ([@B29]). In the exercise training experiment, endothelial nitric oxide synthase (eNOS) in left ventricular murine tissue ([@B64]; [@B146]) elevates the gene expression of PGC-1α ([@B131]). In addition, it is also found that PGC-1α plays an important role in protecting cardiomyocytes from ROS-mediated injury. In the hearts of PGC-1α knockout mice, the basic mRNA expression levels of ROS detoxifying enzymes such as cytoplasmic copper/zinc-SOD1, mitochondrial Mn-SOD, and peroxisome catalase were significantly reduced ([@B121]). However, whether ERR, eNOS and ROS play a role in cardiac exercise adaptation by affecting the expression of PGC-1α needs further study.

PPARα {#s3_2}
-----

The content of PPARα and PPARβ in cardiomyocytes are the highest, while the expression level of PPARγ is low ([@B130]). Although both PPARα and PPARβ were initially considered to be regulators of peroxisome β-oxidation ([@B53]), it was later found that only the activation of PPARα in cardiomyocytes regulated the uptake, oxidation and storage of fatty acids in the heart ([@B42]; [@B23]; [@B81]). Research finds that Cn works by activating PPARα to promote mitochondrial energy production and myocardial growth ([@B136]; [@B128]). Initially, the increasing expression of myocardial peroxisome proliferator-activated receptor (PPARα) was detected during treadmill training in mice ([@B27]). Later, it was found that the level of PPARα also increased in exercise-induced physiologic hypertrophic cardiomyocytes ([@B144]). In addition, some experiments found that gene expression of PPARα was reduced in pathological cardiac hypertrophy, suggesting that upregulation of PPAR-α expression may limit pathological cardiac hypertrophy ([@B13]). However, another study explained that the elevating levels of PPARα may be the result of physiological hypertrophy ([@B105]). These results further illustrated that PPARα may play an important role in inhibiting the transformation from physiological growth to pathological hypertrophy of cardiomyocytes.

AMPK {#s3_3}
----

In skeletal muscle, AMPK is activated during exercise to increase metabolism ([@B137]; [@B138]). AMPK also acts as an important energy sensor and metabolic regulator in the heart ([@B11]). When activated by increasing energy demand, its role is to boost the intake and catabolism of fatty acids ([@B47]). The increase in myocardial stromal metabolism during exercise can be explained by the activation of AMPK ([@B26]). The activation of AMPK can enhance the uptake of long-chain fatty acids (LCFA) in wild-type cardiomyocytes ([@B43]) but not the uptake in CD36 knockout cardiomyocytes ([@B109]), promote the transport of CD36 to the plasma membrane ([@B74]; [@B62]), indicating that AMPK promotes the CD36 expression and transport to raise fatty acid supply. In addition, AMPK plays a role in myocardial metabolism by phosphorylating ACC, a key enzyme that activate fatty acid metabolism ([@B89]; [@B46]). It was found that CD36 expression and ACC phosphorylation are up-regulated in physiologically hypertrophic myocardium induced by exercise training ([@B122]; [@B28]). Thus, AMPK may strengthen the energy supply of exercise-induced myocardial hypertrophy through interaction with CD36 and ACC.

PI3K {#s3_4}
----

Mitochondrial-associated factor phosphatidylinositol 3 kinase (PI3K) signaling and its downstream effectors Akt and GSK-3β promote myocardial physiological hypertrophy growth and maintain normal cardiac function ([@B83]). Although PI3K inhibition can reduce the size of the heart and prevent the adaptation of mitochondria to physiological hypertrophy ([@B115]). However, the downregulation of the effector Akt by PI3K is not necessary for mitochondria to adapt to cardiac hypertrophy, suggesting that there is an independent PI3K signaling pathway in the induction of physiological hypertrophy and may be related to the regulation of mitochondrial metabolism ([@B95]). It was found that the repolarization of K^+^ current amplitude of ventricular myocytes in PI3K cultured group and swimming training induced physiological cardiac hypertrophy group are both higher than that of the wild type, while the expression of transcripts encoding K^+^, Ca^2+^, and other ion channel subunits is elevated, which is parallel to the increased cardiomyocyte size and total cellular RNA expression. It is suggested that the steady-state regulation of physiological myocardial hypertrophy and excitability induced by exercise may be related to myocardial PI3Kα signal ([@B142]), and the normal maintenance of myocardial electrical function is inseparable from energy. Therefore, PI3K may be related to the energy regulation of maintaining electrical excitation homeostasis in exercise-induced physiological myocardial hypertrophy.

IGF-1R and IR {#s3_5}
-------------

Insulin-like growth factor-1 receptor (IGF-1R) has been proved to be an important condition for inducing myocardial physiological growth in mice ([@B84]; [@B63]). In heart-specific IR knockout mice, the expression of PPARα decreased, the level of PGC-1α did not change. Meanwhile, the mitochondrial respiration and ATP synthesis rate were impaired ([@B22]). The deletion of insulin receptor substrate (IRS), which is necessary for IGF-1R and IR signal transduction, preventing the activation of PGC-1α, but increasing the capacity of mitochondria after exercise ([@B103]). These results provide evidence that the coordination of growth procedures and metabolic reprogramming may occur in insulin-like growth factor-1 and insulin triggered signaling pathways.

PKC-α {#s3_6}
-----

Experiments with swimming-trained mice have shown that activation of PKC-α suppresses apoptosis, promotes the growth of physiological cardiomyocytes and improves cardiac function ([@B91]). Excessive activation of PKC-α in the liver affects glucose and fatty acid metabolism. In myocardium, PKC-α activation protects myocardium by improving cardiac mitochondrial function ([@B92]). These related researches of PKC-α indicated that the role of PKC-α in exercise-induced physiological hypertrophy may be associated with the regulation of metabolism.

The Probable Regulatory Mechanism of Energy Metabolism During Exercise-Induced Heart Growth {#s4}
===========================================================================================

Autophagy {#s4_1}
---------

The recycling of cell components by autophagy has become an important process of adaptive response to exercise ([@B45]). Many beneficial effects of exercise may be related to autophagy, especially physiological myocardial hypertrophy caused by exercise. It was found that the activity of autophagy increased significantly in the heart of exercise-induced physiologically hypertrophic rats ([@B100]). Some previous studies have shown that autophagy/mitophagy plays an important role in the adaptation of skeletal muscle to endurance exercise and interacts with mitochondrial organisms ([@B48]; [@B129]; [@B57]). A team found that mitochondrial autophagy-related proteins Beclin1, LC3, and Bnip3 are significantly up-regulated during acute exercise ([@B71]). Therefore, there may be a certain interaction between autophagy and metabolism in exercise-induced physiological hypertrophic cardiomyocytes.

Post-Translational Modification {#s4_2}
-------------------------------

Post-translational modification refers to the process of covalent processing of the translated proteins. There are more than 20 post-translational modification processes in eukaryotic cells, such as acetylation, phosphorylation, ubiquitination, and methylation. The mitochondrial proteome consists of approximately 1100 to 1500 proteins, most of which are encoded by nuclear DNA and transferred to mitochondria after post-translational modification ([@B147]). Studies have found that metabolic adjustment of myocardium during exercise may be related to ACC phosphorylation in fatty acid metabolism ([@B26]). By activating PKC-δ and simultaneously inhibiting PKC-α phosphorylation, the PKC subtype is reversed, resulting in impaired cardiac function during physiological hypertrophy ([@B91]). In addition, a research shows that the protein O-GlcNAcylization in physiologically growing cardiomyocytes in swimming trained mice is reduced as a whole compared to sedentary mice ([@B14]). The O-junction of monosaccharide β-N-acetyl-glucosamine (O-GlcNAcylization) is a post-translational modification on serine and threonine residues, which is an important mechanism for regulating various cellular processes ([@B77]). Another study compared the low and high running ability of rats. The author mentioned the difference in the level of cardiac O-GlcNAcylization of several mitochondrial proteins, among which the O-GlcNAc levels of complex I and complex IV proteins in the low-volume group are higher than high capacity group ([@B56]). Therefore, O-GlcNAcylization may play a role in mitochondrial adaptation to exercise-induced cardiac hypertrophy. Meanwhile, in the physiological cardiac hypertrophy induced by aerobic exercise, PPARβ and histone deacetylase (HDAC) I and II were found to be elevated, accompanied by the interaction between metabolism and epigenetic genes ([@B118]). Deacetylase (HDAC) affects the acetylation of histones, and exercise training can accelerate the up-regulation of HDAC gene expression and increase the acetylation of histones in cardiomyocytes ([@B85]; [@B67]; [@B16]). In addition, myocardium-specific histone deacetylase HDAC3 (a member of HDAC I) plays a unique role in maintaining cardiac function and modulating fatty acid metabolism by regulating histone acetylation in the promoter region of myocardial energy gene ([@B88]). These studies indicated that posttranslational modification may play a complementary role in regulating cardiac growth and myocardial energy metabolism.

MicroRNAs {#s4_3}
---------

MicroRNAs are small non-coding RNA molecules with a length of about 22 nucleotides, which activate the post-transcriptional gene expression by binding to target messenger RNA to promote its degradation. Some animal and human studies have shown that the levels of microRNAs in exercise-induced cardiac hypertrophy have been altered ([**Table 1**](#T1){ref-type="table"}). Among them, the expressions of miR-17-3p, miR-30, miR-21, miR-27a/b, miR-144, miR-145 ([@B133]), miR-29 ([@B117]), miR-19b, miR-208b, and miR-133b ([@B101]) were up-regulated. MiR-1, miR-133, miR-124, miR-143 ([@B133]), miR-341 ([@B80]), miR-100, miR-22, miR-99b, miR-181a, miR-191a ([@B101]), miR-214 ([@B86]), miR-199, miR-222 ([@B113]), miR-26b-5p, miR-204-5p, and miR-497-3p ([@B100]) were down-regulated. MicroRNAs regulate gene expression in hypertrophic myocardium induced by exercise training, in which miR-17-3p and miR-222 may induce cardiomyocyte metabolism and mitochondrial adaptation ([@B113]). Furthermore, inhibition of endogenous miR-199 inducing physiological myocardial hypertrophy may be related to up-regulation of PGC-1α mRNA expression ([@B72]). MiR-1 suppresses the translation of MCU (a kind of mitochondrial calcium transporter), reduces the uptake of mitochondrial Ca^2+^ in cardiomyocyte, and increases the production of metabolic energy ([@B145]). Inhibition of miR-208b increases the expression of epigenetic target proteins, which may stimulate the interaction between metabolism and cell growth ([@B118]). In addition, in a study on the relationship between miRNAs and exercise-induced physiological cardiac hypertrophy, KEGG pathway analysis showed that 12 up-regulated miRNAs are associated with fatty acid degradation, fatty acid metabolism, and fatty acid elongation ([@B141]). These researches indicated that microRNAs may have a certain effect on metabolism in maintaining exercise-induced physiological myocardial hypertrophy. However, the roles of lncRNAs and circRNAs in physiological cardiac hypertrophy have not been reported ([@B134]).

###### 

Overview of microRNA levels altered in exercise-induced physiologic cardiac hypertrophy and their cellular targets.

  MicroRNA     Cellular Target                      Animal Model and Exercise Modality   References
  ------------ ------------------------------------ ------------------------------------ ---------------------
  miR-17-3p    TIMP3, PTEN                          Mice, swimming exercise              ([@B133])
  miR-30       P53, Drp-1                           Mice, treadmill running              ([@B133])
  miR-21       PDCD4                                Mice, treadmill running              ([@B133])
  miR-27a/b    ACE                                  Rats, swimming exercise              ([@B133])
  miR-144      PTEN                                 Rats, swimming exercise              ([@B133])
  miR-145      TSC2                                 Rats, swimming exercise              ([@B133])
  miR-29       collagen                             Rats, swimming exercise              ([@B117])
  miR-19b      PTEN, MuRF, Bcl2, Atrogin-1, αCryB   Rats, swimming exercise              ([@B101])
  miR-208b     THRAP1, Myostatin                    Rats, swimming exercise              ([@B101]; [@B118])
  miR-133b     CyclinD, NelfA, RhoA, Ccd42          Rats, swimming exercise              ([@B101])
  miR-100      IGF1R, Akt, mTOR                     Rats, swimming exercise              ([@B101])
  miR-22       CDK6, Sir1, Sp1                      Rats, swimming exercise              ([@B101])
  miR-99b      IGF1R, Akt, mTOR                     Rats, swimming exercise              ([@B101])
  miR-181a     MAPK1, TNFα, GATA4                   Rats, swimming exercise              ([@B101])
  miR-191a     Egr1, Cd4, Casp4, SOCS4, p53         Rats, swimming exercise              ([@B101])
  miR-1        Bcl-2                                Mice, treadmill running              ([@B145]; [@B133]).
  miR-133      Calcineurin, PI3K/Akt signaling      Rats, swimming exercise              ([@B133])
  miR-124      PI3K                                 Rats, swimming exercise              ([@B133])
  miR-143      ACE2                                 Rats, swimming exercise              ([@B133])
  miR-341      c-Myb                                Mice, treadmill running              ([@B80])
  miR-199      PGC1α                                Mice, treadmill running              ([@B72]; [@B113])
  miR-222      P27, Hipk1, Hmbox1                   Mice, swimming exercise              ([@B113])
  miR-214      SERCA2a                              Rats, leg flexing exercise           ([@B86])
  miR-26b-5p   LC3B, Beclin1, SQSTM1                Rats, swimming exercise              ([@B100])
  miR204-5p    LC3B, Beclin1, SQSTM1                Rats, swimming exercise              ([@B100])
  miR-497-3p   LC3B, Beclin1, SQSTM1                Rats, swimming exercise              ([@B100])

Angiogenesis {#s4_4}
------------

VEGFs are main regulators of myocardial angiogenesis. Some studies have found that inhibition of VEGFs signal transduction leads to capillary thinning and early heart failure ([@B54]; [@B110]), indicating that cardiomyocytes may produce angiogenic factors to maintain capillary density, oxygen supply, and function. The number of myocardial capillaries increased significantly in physiological myocardial hypertrophy ([@B8]; [@B93]), while the capillary density was attenuated in pathological myocardial hypertrophy ([@B7]; [@B15]), suggesting that the number of myocardial capillaries is controlled by the myocardium, and the decrease in capillary density may cause hypoxia or even contraction dysfunction. Therefore, the growth of physiologically hypertrophic cardiomyocytes induced by exercise may be related to angiogenesis providing a good oxygen supply for myocardial metabolism.

Inflammation {#s4_5}
------------

There are total 59 genetic variation in the study of physiological cardiac hypertrophy in swimming mice or treadmill rats, only two genes (Cd74 and Col3a1) are changed in both mice and rat models. The immune-function related gene Col3a1 was down-regulated in response to exercise in mice (1.6, 3.1-fold) and rats (1.8-fold) but up-regulated in most pathological cardiac hypertrophy models ([@B36]). In the study of cardiac cell RNA sequencing, it was found that one of the most significant difference in the physiologically hypertrophic myocardium induced by swimming training was the severe downregulation of the autoimmunity pathway, accompanied by the obvious selective splice of exon variants (AS) ([@B119]). In addition, in a study using high-density oligonucleotide microarray to detect myocardial gene expression profiles in physiologically and pathologically hypertrophic rats, inflammation-related genes (such as pancreatitis-associated proteins and arachidonic acid 12 lipoxygenase) increased in the pathological process, but not in physiological hypertrophy ([@B66]). At the molecular level, the up-regulated expression of Rho kinase promoted inflammation. Fasudil is an inhibitor of Rho kinase. It was found that fasudil could significantly reduce the left ventricular dysfunction of pathological myocardial hypertrophy caused by partial aortic constriction (PAAC), but has no significant regulatory effect on left ventricular hypertrophy induced by chronic swimming training (CST). These results suggest that Rho kinase is involved in PAAC-induced pathological myocardial hypertrophy ([@B12]). However, it is not ruled out that the regulatory effect of Rho kinase on physiological hypertrophy is not obvious due to the down-regulation of immune pathway in physiological cardiac hypertrophy induced by CST. It remains further explored whether the down-regulation of this immune pathway affects the energy metabolism of the myocardium.

Conclusions {#s5}
===========

Metabolic remodeling is closely related to the occurrence and development of cardiac hypertrophy and other heart diseases. Exploring the energy metabolism mechanism of cardiomyocytes may lead to new therapeutic targets, which will be helpful to design new effective methods and strategies for the treatment of heart failure ([@B20]; [@B78]; [@B148]). As we all know, physical exercise has a protective effect on the heart, and can even partially compensate for heart damage and improve heart function. Combined with the metabolic adaptation pathway observed in the studies of myocardial physiological hypertrophy induced by exercise, we can further explore how exercise-induced metabolic adaptation coordinate cell signals and gene expression, which may be helpful to guide exercise training scientifically, maximize the benefits of exercise, improve heart health, and develop new treatment strategies for the treatment of heart failure caused by various complex reasons and aging in the future.
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